Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 89.8% of Iovance […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) – Research analysts at Zacks Research dropped their Q2 2023 EPS estimates for Iovance Biotherapeutics in a research report issued on Tuesday, May 23rd. Zacks Research analyst S. Ganoria now forecasts that the biotechnology company will post earnings per share of ($1.43) for the quarter, down from their […]
Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) and Iovance Biotherapeutics (NASDAQ:IOVA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations. Analyst Ratings This is a summary of recent recommendations […]